No blood clot risk from Covaxin or Covishield, says top panel
A top government official said that the panel analysed over 400 major adverse reactions during the ongoing vaccination drive and submitted its findings.
The AstraZeneca vaccine was manufactured in India by the Serum Institute of India...
A top government official said that the panel analysed over 400 major adverse reactions during the ongoing vaccination drive and submitted its findings.
The revised interval applies only to Serum Institute of India's Covishield and not to Bharat Biotech's Covaxin, the Centre said in its letter.
Corona virus infection is increasing rapidly in the country once again. Measures such as lockdown night curfew are being taken to prevent the spread of corona.
Even those who register without registration can get vaccination done from 3 pm to 9 pm
During the last 24 hours, 40953 new cases were reported and 188 infected people died. The total number of infected people in the country so far has gone up to 11555284 and the number of deaths has increased to 159558.
Nepal gives a green signal to the Covexin Corona vaccine made in India for emergency use. Nepal has become the third country in the world to validate this biotech vaccine.Covaxin has been 81% effective in final-stage trials on 26,000 people in India.
Coronavirus, which started in Wuhan, China, is constantly taking new forms. In France, a corona strain has been found that is being hidden when swab from the nose. There have been 79 corona cases in Britain, France, but many people have come negative in the investigation.
The woman, who has only breastfed the baby, received a second dose of the vaccine according to the standard duration of the 28-day vaccination guide.